How severe is CVE-2022-38351?

CVE-2022-38351 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2022-38351 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (55th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-38351?

CVE-2022-38351 affects Supremainc Biostar 2. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-38351?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2022-38351 published?

CVE-2022-38351 was published on 2022-09-19 and last updated on 2026-06-17.

CVE-2022-38351

CVE-2022-38351 is a high-severity vulnerability in Supremainc Biostar 2 with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-269.

Key facts

Severity: High (CVSS 3.x base score 8.8)
EPSS exploit prediction: 1% (55th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-269
Affected product: Supremainc Biostar 2
Published: 2022-09-19
Last modified: 2026-06-17

Description

A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.

Frequently asked questions

What is CVE-2022-38351?: A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.
How severe is CVE-2022-38351?: CVE-2022-38351 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-38351 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (55th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-38351?: CVE-2022-38351 affects Supremainc Biostar 2. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-38351?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-38351 published?: CVE-2022-38351 was published on 2022-09-19 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:supremainc:biostar_2:2.8.16:*:*:*:*:*:*:*

More vulnerabilities in Supremainc Biostar 2

CVE-2023-33366 — High (CVSS 8.8): A SQL injection vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows authenticated users to inject…
CVE-2023-33364 — High (CVSS 8.8): An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to…
CVE-2023-31923 — High (CVSS 8.8): Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an…
CVE-2023-33365 — High (CVSS 7.5): A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to…
CVE-2023-33363 — High (CVSS 7.5): An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to…
CVE-2020-15050 — High (CVSS 7.5): An issue was discovered in the Video Extension in Suprema BioStar 2 before 2.8.2. Remote attackers can read arbitrary…

All CVEs affecting Supremainc Biostar 2 →

Other CWE-269 (Improper Privilege Management) vulnerabilities

CVE-2026-31852 — Critical (CVSS 10.0): Jellyfin is an open-source media system. The code-quality.yml GitHub Actions workflow in jellyfin/jellyfin-ios is…
CVE-2025-20282 — Critical (CVSS 10.0): A vulnerability in an internal API of Cisco ISE and Cisco ISE-PIC could allow an unauthenticated, remote attacker to…
CVE-2025-0505 — Critical (CVSS 10.0): On Arista CloudVision systems (virtual or physical on-premise deployments), Zero Touch Provisioning can be used to gain…
CVE-2023-48418 — Critical (CVSS 10.0): In checkDebuggingDisallowed of DeviceVersionFragment.java, there is a possible way to access adb before SUW…
CVE-2023-48419 — Critical (CVSS 10.0): An attacker in the wifi vicinity of a target Google Home can spy on the victim, resulting in Elevation of Privilege
CVE-2023-31273 — Critical (CVSS 10.0): Protection mechanism failure in some Intel DCM software before version 5.2 may allow an unauthenticated user to…

Browse all CWE-269 (Improper Privilege Management) vulnerabilities →